Stamford, CT -- (SBWIRE) -- 12/13/2013 -- Wall Street Pennies is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Sunedison Inc (NYSE:SUNE), Avanir Pharmaceuticals Inc (NASDAQ:AVNR), Synthetic Biologics Inc (NYSEMKT:SYN), Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY).
Sunedison Inc (NYSE:SUNE) ended its recent business day with the loss of -10.32% and closed at the price of $11.47 after opening at $12.07. The stock traded during its last trading session with the total volume of 36.33 million shares, as compared to its average volume of 8.17 million shares. SunEdison, Inc. develops, manufactures, and sells silicon wafers. The company is also involved in developing and selling photovoltaic energy solutions. It operates in two segments, Semiconductor Materials and Solar Energy.
Has SUNE Found The Bottom and Ready To Move Up? Find Out Here
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) remained among the day advancers and traded with volume of 7.87 million shares in the last session, as compared to average volume of 2.13 million shares. In comparison with 52 week range of $2.34 - $6.00, it faced lowest price of $3.10 during the last trading session whereas its day highest price was $3.43. The company’s total market capitalization is $458.23 billion, along with 145.47 million shares outstanding. Avanir Pharmaceuticals, Inc., together with its subsidiaries, engages in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States.
For How Long AVNR’s Gloss will Attract Investors? Find out via this report
Synthetic Biologics Inc (NYSEMKT:SYN) showed 4.57 million shares in volume during the last trading session, while the average trading volume remained 112.538.00 shares. The stock kicked off its trading session at $1.02 and closed at $1.04 after declining -18.11%. Synthetics Biologics, Inc., a biotechnology company, focuses on the development of biologics for the prevention and treatment of serious infectious diseases. The company’s product candidates include Trimesta, which is in Phase II clinical trial for the treatment of relapsing-remitting multiple sclerosis and cognitive dysfunction in multiple sclerosis.
Why Should Investors Buy SYN After the Recent Fall? Just Go Here and Find Out
Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) stock traded during its last trading session with the total traded volume of 1.56 million shares versus its average volume of 418,173.00 million shares. The company opened its trade at the price of $66.71 and its closing price was $66.35 after losing -1.19% for the day. Roche Holding AG operates in the pharmaceuticals and diagnostics businesses in Switzerland, European Union, and internationally. It discovers, develops, and delivers diagnostic and therapeutic products and services that enable patients and healthcare professionals in the detection, prevention, diagnosis, treatment, and treatment monitoring of diseases.
Will RHHBY Get Buyers Even After The Recent Rally? Find Out Here
About Wall Street Pennies:
Wall Street Pennies is always penetrating the market every day for enormous penny stock runs before they happen in order to assist its customers. Our Penny Stock Newsletter also offers free market strategies and analysis from one of the most experienced and well-respected chartists in the penny stock industry.
Carriage Consulting Group, www.wallstreetpennies.com,, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “www.wallstreetpennies.com,”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. Wall Street Pennies as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by www.wallstreetpennies.com, as defined.
Read full Disclaimer at: http://wallstreetpennies.com/financial-disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)